NSC |
Compound |
Enrichment |
Correlation |
NSC 339638 |
2H-Pyran-2-one, 5,6-dihydro-6-[3,6,13-trihydroxy-3-methyl- 4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-, monosodiumsalt |
0.0115521552688255 |
0.20374468 |
NSC 352741 |
Null |
0.0115521552688255 |
0.31962049 |
NSC 54849 |
Null |
0.0115521552688255 |
0.16737352 |
NSC 618262 |
Null |
0.0115521552688255 |
0.35266567 |
NSC 623527 |
Pyrrolidinium, N-(5-carboxypentyl)-N- [2-[2-[3-(octadecyloxy)-2-[(pyrimidine-2yl)oxy]propyloxy] ethoxy]ethyl]-, inner salt |
0.0115521552688255 |
0.25194256 |
NSC 626673 |
Null |
0.0115521552688255 |
0.21427636 |
NSC 630307 |
Null |
0.0115521552688255 |
0.40036891 |
NSC 639503 |
Cyclopentanone, 2-hexylidene-5-[(4-morpholinyl)methyl]-, hydrochloride |
0.0115521552688255 |
0.46028663 |
NSC 639512 |
Cyclopentanone, 2-[(4-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride |
0.0115521552688255 |
0.3051308 |
NSC 641297 |
ANTINEOPLASTIC-641297 |
0.0115521552688255 |
0.2184319 |